The Central Government informed the Kerala High Court on Wednesday that the Centre has provided the state with 60 per cent more vaccine doses than the proposed allocation.
The statement was filed after the High Court sought a reply from the Union Government in a plea, filed by petitioners KP Aravindan and Dr Praveen G Pai, challenging the Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy.
The Centre said, "It supplied adequate doses of COVID vaccines to Kerala under the National COVID-19 Vaccination programme. Vaccines were supplied to States and Union Territories on a proportional basis of the eligible population, the progress of vaccination, and vaccine wastage."
Assistant Solicitor General P Vijayakumar, appearing for the Union Government, said in the submission, "As per the vaccine allocation for July 2021, the State was entitled to the allocation of 39,02,580 vaccines doses. However, it was supplied with 61,36,720 doses last month according to the report. This is 60% more than the proposed allocation for the State."
The Assistant Solicitor General said, "The Centre has provided enhanced supplies to the state in terms of vaccine distribution, citing that Kerala has vaccinated 55 per cent of its eligible population with the 1st dose compared with the national average of 42 per cent. The State has vaccinated 22 per cent of its population against 12 pc of the national average. So, Kerala has been supplied adequate doses of the vaccines under the National COVID-19 Vaccination Programme. The State would continue to be supplied adequate doses as per the availability of vaccines."
Petitioner Aravindan is a member of the COVID-19 expert panel constituted by the State and Pai is a public health specialist.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)